COMAI, GIORGIA
 Distribuzione geografica
Continente #
AS - Asia 13.669
NA - Nord America 10.097
EU - Europa 7.420
AF - Africa 752
SA - Sud America 691
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 13
Totale 32.673
Nazione #
US - Stati Uniti d'America 9.912
VN - Vietnam 4.389
SG - Singapore 3.395
CN - Cina 2.989
IT - Italia 1.946
GB - Regno Unito 1.320
HK - Hong Kong 1.122
DE - Germania 967
SE - Svezia 763
FR - Francia 514
IN - India 495
BR - Brasile 482
KR - Corea 378
RU - Federazione Russa 311
IE - Irlanda 287
NL - Olanda 280
UA - Ucraina 257
FI - Finlandia 226
TG - Togo 202
JP - Giappone 178
ZA - Sudafrica 145
CI - Costa d'Avorio 143
SC - Seychelles 113
CA - Canada 103
JO - Giordania 99
AR - Argentina 91
EE - Estonia 86
PH - Filippine 86
BG - Bulgaria 85
BD - Bangladesh 77
AT - Austria 74
TH - Thailandia 73
ID - Indonesia 70
NG - Nigeria 65
IQ - Iraq 56
MX - Messico 52
PL - Polonia 48
TW - Taiwan 47
BE - Belgio 45
CH - Svizzera 45
TR - Turchia 41
ES - Italia 40
EC - Ecuador 37
PK - Pakistan 34
IR - Iran 29
AU - Australia 27
SA - Arabia Saudita 27
CO - Colombia 24
GR - Grecia 19
CL - Cile 16
EG - Egitto 16
MA - Marocco 15
PY - Paraguay 15
LT - Lituania 14
UZ - Uzbekistan 14
RO - Romania 13
KE - Kenya 12
CZ - Repubblica Ceca 11
AL - Albania 10
DZ - Algeria 10
MY - Malesia 10
DK - Danimarca 9
HR - Croazia 8
PE - Perù 8
VE - Venezuela 8
XK - ???statistics.table.value.countryCode.XK??? 8
CR - Costa Rica 7
KZ - Kazakistan 7
RS - Serbia 7
AE - Emirati Arabi Uniti 6
BA - Bosnia-Erzegovina 6
ET - Etiopia 6
NP - Nepal 6
TN - Tunisia 6
IL - Israele 5
LB - Libano 5
UY - Uruguay 5
EU - Europa 4
HU - Ungheria 4
JM - Giamaica 4
SV - El Salvador 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
GT - Guatemala 3
HN - Honduras 3
LK - Sri Lanka 3
MD - Moldavia 3
MK - Macedonia 3
OM - Oman 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AO - Angola 2
CG - Congo 2
GA - Gabon 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
Totale 32.624
Città #
Singapore 2.395
Ashburn 1.418
Ho Chi Minh City 1.130
Southend 1.053
Hong Kong 1.032
Hanoi 1.025
Hefei 749
San Jose 707
Chandler 701
Fairfield 610
Santa Clara 443
Bologna 362
Beijing 353
Seoul 333
Ann Arbor 314
Wilmington 313
Houston 309
Woodbridge 299
Dublin 283
Princeton 279
Seattle 260
Los Angeles 245
Cambridge 220
Dong Ket 210
Lomé 202
Boardman 198
Lauterbourg 183
Helsinki 172
Da Nang 170
Tokyo 153
Jacksonville 145
Abidjan 143
Council Bluffs 138
Haiphong 134
New York 132
Dallas 129
Munich 120
Frankfurt am Main 118
Milan 117
Westminster 112
Buffalo 110
Nanjing 109
Amman 99
Turin 99
Berlin 95
Padova 86
Sofia 83
Redondo Beach 74
Bremen 71
Bengaluru 69
Rome 69
Florence 66
Jinan 65
Hyderabad 64
Biên Hòa 62
Redmond 60
Hải Dương 59
Abeokuta 58
São Paulo 58
Chicago 53
Changsha 52
The Dalles 52
Guangzhou 51
Medford 49
Shenyang 47
Phoenix 46
London 45
Saint Petersburg 45
Amsterdam 44
Brussels 44
Falkenstein 42
Johannesburg 42
Shanghai 42
Thái Nguyên 41
Vienna 41
Nuremberg 40
Jakarta 39
Toronto 39
Des Moines 37
Orem 37
Warsaw 37
Ha Long 36
Nanchang 36
Tianjin 36
San Diego 35
San Francisco 35
Zhengzhou 35
Can Tho 34
Modena 34
Ninh Bình 34
Redwood City 33
Bắc Ninh 32
Thái Bình 32
Atlanta 31
Bangkok 31
Dearborn 31
Montreal 30
Quận Bình Thạnh 30
Hebei 29
Pune 29
Totale 20.453
Nome #
Long Term Outcomes of Kidney Transplant: Characteristics of Recipients with 20 or More Years of Graft Survival 886
Stem Cells 365
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 326
Acute granulomatous interstitial nephritis and ulcerative colitis: A case report and literature review 292
COLONIZZAZIONE ED INFEZIONE DA KLEBSIELLA PNEUOMONIAE PRODUTTRICE DI CARBAPENEMASI (KPC) NEL PAZIENTE SOTTOPOSTO A TRAPIANTO DI RENE 285
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 273
Automatic Adaptive System Dialysis for Hemodialysis-Associated Hypotension and Intolerance: A Noncontrolled Multicenter Trial. 272
5-Methyltetrahydrofolate Administration Is Associated with Prolonged Survival and Reduced Inflammation in ESRD Patients 272
Correlazioni tra decoy cells urinarie, viremia BK e terapia immunosoppressiva nel trapianto di rene 262
Cardiovascular Disease in Kidney Transplant Recipients: The Prognostic Value of Inflammatory Cytokine Genotypes. 262
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 249
Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial 243
Seroprevalence of a “new” bacterium, Simkania negevensis, in renal transplant recipients and in hemodialysis patients 240
Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients 236
Combined application of Hemodiafiltration and Profiler: short and mid-term clinical results in 16 patients. 226
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis 226
An in vivo autotransplant model of renal preservation: cold storage versus machine perfusion in the prevention of ischemia/reperfusion injury. 226
Delayed Graft Function (DGF) e Trapianto Renale: studio dei principali fattori di rischio. 223
Donor/recipient delta age: A possible risk for arterial stenosis in renal transplantation 219
DNA VIRAL INFECTIONS ASSAY IN KIDNEY TRANSPLANT RECIPIENTS BY A NEW HIGH THROUGHPUT MASS SPECTROMETRY METHOD 216
Combined liver–dual kidney transplant: Role in expanded donors 215
Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. 213
Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants 212
Methylenetetrahydrofolate reductase, MTHFR, polymorphisms and predisposition to different multifactorial disorders 212
Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review 211
Impact of cytokines and apoptosis molecules polymorphisms on Chronic Allograft Nephropathy 209
Nephrological indications in combined liver kidney transplantation 208
INDICAZIONI NEFROLOGICHE AL TRAPIANTO COMBINATO RENE-FEGATO 207
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 206
A case report of IgG4-related disease: an insidious path to the diagnosis through kidney, heart and brain 206
Identification of asymptomatic Leishmania infection in patients undergoing kidney transplant using multiple tests 204
Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. 203
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 200
Acute Kidney Injury and Blood Purification Techniques in Severe COVID-19 Patients 199
INFLUENCE OF DELAYED GRAFT FUNCTION (DGF) ON RENAL TRANSPLANTATION OUTCOME 199
Impiego clinico del “Fegato Artificiale” MARS: effetti sulle citochine e sui fattori di crescita 199
Reduction of Oxidative Damage Reflects a Better Kidney Transplantation Outcome. 199
Increase in Serum Amylase and Resistive Index After Kidney Transplant Are Biomarkers of Delayed Graft Function 199
“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy 197
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 195
Genetic Factors and Risk OF Acute Rejection in Kidney Transplant 194
Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors 194
Warfarin anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters thrombosis. 193
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 193
A very early and acute renal impairment due to polyomavirus allograft nephropathy. 192
Urinary neutrophil gelatinase-associated lipocalin is a biomarker of delayed graft function after kidney transplantation 192
An in vitro model of renal inflammation after ischemic oxidative stress injury: Nephroprotective effects of a hyaluronan ester with butyric acid on mesangial cells 192
Uremic Serum Impairs Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stromal Cells 189
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 187
Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study 186
Incidenza di Rigetto Acuto nel Trapianto Renale: ruolo dei fattori genetici 186
Fifteen-year analysis of deceased kidney donation: A single transplant center experience in a region of northern Italy 186
Impiego combinato HFR-Profiler: risultati clinici a breve-medio termine 185
Schemi di terapia immunosoppressiva e livelli ematici consigliati 183
Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome 183
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 183
Chronic allograft dysfunction: role of immunosuppressive treatment 180
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability 179
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 179
Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease 179
Removal of free light chains in hemodialysis patients without multiple myeloma: A crossover comparison of three different dialyzers 179
RESISTENZA AL FLUSSO E MARKERS METABOLICI COME STRUMENTI DI VALUTAZIONE D’ORGANO PER IL TRAPIANTO DI RENI MARGINALI: STUDIO PROSPETTICO ITALIANO SULLA PERFUSIONE IPOTERMICA OSSIGENATA 179
DOPPI TRAPIANTI DI RENE MONOLATERALI CON RICOSTRUZIONI VASCOLARI A BANCO IN GRFAFT CON VASI MULTIPLI E RICEVENTI SEVERAMENTE ATEROMASICI 178
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function 177
Prevenzione della trombosi dei cateteri a permanenza per emodialisi: profilassi mediante anticoagulazione con warfarin 176
Cabozantinib-induced renal thrombotic microangiopathy 175
Polimorfismo del Vascular Endothelial Growth Factor e rischio cardiovascolare dopo trapianto renale 174
Treatment of Acute Antibody-Mediated Rejection 174
Histological findings of diabetic kidneys transplanted in non-diabetic recipients: a case series 172
Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies 171
Corrigendum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2020;97:1287–1296 (Kidney International (2020) 97(6) (1287–1296), (S0085253820301526), (10.1016/j.kint.2020.01.035)) 170
Influence of delayed graft function (DGF) on renal transplantation outcome 168
Outcome of kidney function in adults on long-term home parenteral nutrition for chronic intestinal failure 168
Babesiosis in the immunocompromised population: Results from a multicentric cohort study conducted in Italy 167
Perfusione Continua versus Ipotermia Semplice nel Trapianto d’organo. Studio sperimentale su modello animale. 167
Score istologico pre-trapianto e outcome del trapianto renale 167
Hematopoietic Cell and Renal Transplantation in Plasma Cell Dyscrasia Patients. 167
Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic 166
Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome 166
Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report 166
Risk factors for IgA nephropathy recurrence and impact on graft survival in a cohort of kidney transplanted patients 165
Risk Factors of Acute Rejection: Impact on Graft Outcomes in a Cohort of Kidney Transplant Recipients 164
Early Light Chains Removal and Albumin Levels with a Double Filter-Based Extracorporeal Treatment for Acute Myeloma Kidney 164
SP714SHEAR WAVE ELASTOGRAPHY IN KIDNEY TRANSPLANTATION: NONINVASIVE ALTERNATIVE TO ALLOGRAFT BIOPSY? 164
RUOLO DELL'ISTOLOGIA NELLA DELAYED GRAFT FUNCTION 164
Double Single-Side Kidney Transplants With Bench Vascular Reconstruction: A Further Challenge Beyond the Marginality Without Future Preclusions 164
Nephrological indications in combined liver-kidney transplantation. 163
Urine-Derived Renal Epithelial Cells (URECs) from Transplanted Kidneys as a Promising Immunomodulatory Cell Population 162
Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant 162
THE USE OF 3D AUGMENTED REALITY DURING ROBOT-ASSISTED LIVING DONOR NEPHRECTOMY (RALDN): A CASE REPORT TECHNICAL OVERVIEW 161
Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus. 160
Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin. 159
Normothermic and hypothermic oxygenated perfusion for donation after circulatory death in kidney transplantation: Do we pay higher risk of severe infection after transplantation?: A case report 159
Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates 159
Renal Vessel Extension With Cryopreserved Vascular Grafts: Overcoming Surgical Pitfalls in Living Donor Kidney Transplant 159
Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease 159
Alungamento dei vasi renali mediante allograft vascolari criopreservati: è possibile ottimizzare le problematiche tecniche nel trapianto da vivente con graft destri o vascolarizzazione anomala? 158
Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study 158
Jugular vein-mammary artery fistula after catheterism for hemodialysis: case report. 158
[Membranous glomerulonephritis (MGN), ongoing studies] 158
Totale 20.274
Categoria #
all - tutte 82.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021575 0 0 0 0 0 0 0 0 0 0 79 496
2021/20222.708 183 137 175 205 246 174 73 202 119 180 549 465
2022/20233.436 305 487 166 437 253 293 108 195 631 96 303 162
2023/20241.248 79 184 63 127 79 251 67 117 38 86 85 72
2024/20255.366 250 619 504 299 663 257 329 183 112 368 491 1.291
2025/202615.123 2.262 1.536 1.089 996 1.376 767 2.296 467 2.890 1.155 289 0
Totale 33.347